Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

CUSIP: 09627Y109

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
65,000,000
Total 13F shares
26,029,473
Share change
+6,159,246
Total reported value
$730,115,893
Put/Call ratio
104%
Price per share
$28.05
Number of holders
101
Value change
+$172,572,667
Number of buys
67
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 09627Y109?
CUSIP 09627Y109 identifies BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2016

As of 31 Dec 2016, Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by 101 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,029,473 shares. The largest 10 holders included FMR LLC, BVF INC/IL, DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, LORD, ABBETT & CO. LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, Opaleye Management Inc., and Cormorant Asset Management, LLC. This page lists 101 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.